Annual Report and Accounts 2010/11 - Cancer Research UK

Notes to the Accounts
(continued)
18. Negative goodwill
At 1 April 2010
Amortisation
Group
2011
£000
(5,572)
778
Group
2010
£000
(6,349)
777
At 31 March 2011 (4,794) (5,572)
19. Debtors
Trade debtors
Amounts due from Group undertakings
Taxation recoverable
Other debtors
Prepayments
Accrued legacy income
Accrued other income
Group
2011
£000
5,359
–
10,343
1,748
10,946
80,710
9,257
Group
2010
£000
5,780
–
10,371
21,891
11,901
81,335
9,103
Charity
2011
£000
4,394
4,935
10,418
1,480
9,982
80,710
3,314
Charity
2010
£000
4,194
4,191
10,472
21,533
10,620
81,335
3,761
118,363 140,381 115,232 136,106
Other debtors include balances due after more than one year of £0.9 million (2010: £1.1 million). A small proportion of accrued
legacy income may be received after more than one year, but a figure has not been calculated due to the inherent uncertainty in
the timing of legacy income receipt.
Other debtors at 31 March 2010 included £19.3 million proceeds of sale of Charity freehold properties. This was received in full
in 2011.
The Charity has made a loan to its trading subsidiary company Cancer Research Technology Ltd (CRT) amounting to £1 million.
The loan is secured on the assets of CRT, excluding intellectual property, and attracts interest at base rate plus 1%. The amount
outstanding is repayable in full on 31 March 2015 or on 13 calendar months’ notice from the Charity.
20a) Creditors: amounts falling due within one year
Research grants payable
Life chairs and fellowships
Trade creditors
Amounts due to Group undertakings
Tax and social security creditors
Other creditors
Accruals
Deferred income
Group
2011
£000
127,083
786
9,199
–
4,415
2,114
27,715
19,816
Group
2010
£000
144,324
1,273
11,535
–
4,068
2,473
23,353
15,768
Charity
2011
£000
127,083
481
6,625
20,142
4,312
1,974
19,243
15,082
Charity
2010
£000
144,324
1,134
7,656
24,588
3,956
2,462
15,157
10,297
191,128 202,794 194,942 209,574
46 / Annual Report and Accounts / Notes to the Accounts